Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Trial of CVN424 in Early Parkinson's Disease

NCT06006247 is registered in ClinicalTrials.gov with Cerevance Beta, Inc. as lead sponsor.

NCT NCT06006247
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06006247 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Trial of CVN424 in Early Parkinson's Disease
Lead sponsor
Cerevance Beta, Inc.
Phase
Phase 2
Overall status
Completed
Start date
September 11, 2023
Completion date
February 13, 2025
Enrollment
64 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease